aukelso
(Denosumab-Kyqq)Biocon Biologics Inc.
RANK Ligand Inhibitor [EPC] class drugs
17 results
bildyos - denosumab injection, solution
(Denosumab)Organon Llcbilprevda - denosumab injection, solution
(Denosumab)Organon Llcbomyntra - denosumab injection
(Denosumab)Fresenius Kabi Usa, Llcboncresa
(Denosumab-Mobz)Amneal Pharmaceuticals Llcbosaya
(Denosumab-Kyqq)Biocon Biologics Inc.conexxence - denosumab injection
(Denosumab)Fresenius Kabi Usa, Llcdenosumab - bmwo - denosumab - bmwo injection
(Denosumab-Bmwo)Celltrion Usa, Inc.Usage: Denosumab-bmwo is indicated for preventing skeletal-related events in multiple myeloma and bone metastases, treating unresectable giant cell tumor of bone in adults and adolescents, and managing hypercalcemia of malignancy that is resistant to bisphosphonate therapy.denosumab - bmwo - denosumab - bmwo injection
(Denosumab-Bmwo)Celltrion Usa, Inc.Usage: Denosumab-bmwo is indicated for treating postmenopausal women and men with osteoporosis at high fracture risk, glucocorticoid-induced osteoporosis, and for increasing bone mass in men receiving androgen deprivation therapy for prostate cancer or women on aromatase inhibitor therapy for breast cancer.enoby
(Denosumab-Qbde)Hikma Pharmaceuticals Usa Inc.